Sanofi And Korea’s Hanmi Ink Co-marketing Deal That Could See Sanofi Selling Hanmi’s Irbestin Abroad
This article was originally published in PharmAsia News
Executive Summary
Sanofi and Korea’s Hanmi sign a co-marketing agreement that may see both companies marketing Hanmi’s fixed-dose combination products beyond Korea.